YTEN News and Press, Yield10 Bioscience Inc. From 02/04/21

Gainers: Summit Midstream Partners  (SMLP) +20%, Yield10 Bioscience (YTEN) +12%, Amplify Energy (AMPY) +12%, Independence Contract Drilling (ICD) +10%, Molecular Data (MKD) +8%.Losers: Peabody Energy (BTU) -16%, Patterson-UTI Energy (PTEN) -10...

WOBURN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per...

Concert Pharmaceuticals (CNCE) -47% after CTP-692 study in schizophrenia fails to meet primary or secondary endpoint.Universal Security Instruments (UUU) -18%.Quotient (QTNT) -15% despite FQ3 beat.Yield10 Bioscience (YTEN) -14% after pricing share offering.17 Edu...

Yield10 Bioscience (YTEN) has priced its public offering of 1.04M common shares at $12.25/share, for gross proceeds of ~$12.7M. Closing date is February 3.Maxim Group is acting as the sole book-running manager.Previously (Jan. 29): Yield10 Bioscience under pressure on launching stock offering...

WOBURN, Mass., Jan. 31, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the pricing of its underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share. The gross pro...

Yield10 Bioscience (YTEN) traded 2.6% down in after hours after commencing an underwritten public offering.Offer size, terms have not yet been disclosed. For further details see: Yield10 Bioscience under pressure on launching stock offering

WOBURN, Mass., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has commenced an underwritten public offering of shares of its common stock. The public offering is subject to market conditions, and there can be...

Agricultural bioscience company Yield10 Bioscience ([[YTEN]] -10.9%) announces successful field testing of prototype lines of oilseed Camelina sativa that have been programmed to produce PHA bioplastics directly in seed.PHA bioplastics could ultimately be used to manufacture a wide range...

WOBURN, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced successful field testing of prototype lines of the oilseed Camelina sativa that have been programed to produce PHA bioplastics directly in seed. ...

ProPhase Labs (PRPH) -23% after pricing equity offering.Neovasc (NVCN) -18%.Biohaven Pharmaceutical (BHVN) -13%.Yield10 Bioscience (YTEN) -12%.Technical Communications (TCCO) -10% after receiving delisting notice from Nasdaq.InVivo Therapeutics (NVIV) -8%.Lumentum Holdings (LIT...